Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis after it failed to meet efficacy goals in an ...

Nemolizumab, which targets the interleukin-31 pathway, rapidly improves itch and sleep in people with atopic dermatitis and ...

Adults with atopic eczema are significantly more likely to experience suicidal thoughts than those without the skin condition ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

An NIH study was a beacon for the topical steroid withdrawal community. Then, amid federal upheaval, the research stalled.

A recently approved injectable eczema drug provides quick itch relief to patients with the maddening skin disease, a new ...

Vixarelimab showed significant symptom relief and disease progression reduction in prurigo nodularis compared with placebo across all doses. A phase 2b trial found vixarelimab rapidly reduced itch and ...

A new study from North Carolina State University found that neutrophils—white blood cells that are a key part of the immune ...

Sleep loss from itching is one of the hardest parts of caring for a child with eczema. Here’s a guide to relieving night flares — and helping the whole family rest easier.

The National Eczema Association details seven different kinds of eczema on its website, noting that atopic dermatitis is most common, affecting about half of eczema sufferers.